Key facts
- This page summarizes William R. Enquist's Form 4 filing for Ra Medical Systems, Inc. (VTAK).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jun 2021, 20:02.
William R. Enquist - 04 Jun 2021 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)
- Reporting relationship
- Director
- Issuer ticker
- VTAK
- Reported as of
- 04 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Daniel Horwood, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
William R. Enquist filed Form 4 for Ra Medical Systems, Inc. (VTAK) on 08 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMED
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,000
- Change %
- +27%
- Price
- $0.000000
- Shares after
- 18,766
- Date
- 04 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
RMED
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,263
- Date
- 04 Jun 2021
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service.
Footnote F2
Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee.